Delgocitinib Cream Performs Well in Teens With CHE
Delgocitinib cream (Anzupgo, Leo Pharma) performed well in teens with moderate to severe chronic hand eczema (CHE), according to the DELTA TEEN trial. DELTA TEEN is a pivotal Phase 3 clinical trial with delgocitinib 20mg/g cream, a topical pan-Janus kinase (JAK) inhibitor, for the potential treatment of adolescents (aged 12-17) with moderate to severe CHE […]